Presentation TCT 2025 Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes Presenter: Michael J. Mack October 27, 2025
Presentation TCT 2025 Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II) Presenter: Josep Rodés-Cabau October 26, 2025
Presentation NY Valves 2025 Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials Presenter: Yasser M. Sammour June 25, 2025